Vranizan, Karen M.

Atherogenic lipoprotein phenotype. A proposed genetic marker for coronary heart disease risk

Austin, M. A., King, M. C., Vranizan, K. M., & Krauss, R. M. (1990) · Circulation

Lipoproteins and Cardiovascular HealthLipid metabolism and disorders

Cited by 1,411

ASSESSMENT OF HABITUAL PHYSICAL ACTIVITY BY A SEVEN-DAY RECALL IN A COMMUNITY SURVEY AND CONTROLLED EXPERIMENTS

BLAIR, S. N., HASKELL, W. L., HO, P., PAFFENBARGER, R. S., VRANIZAN, K. M., FARQUHAR, J. W., & WOOD, P. D. (1985) · American Journal of Epidemiology

Physical Activity and HealthCardiovascular and exercise physiology

Cited by 1,104

The Role of Black and Hispanic Physicians in Providing Health Care for Underserved Populations

Komaromy, M., Grumbach, K., Drake, M., Vranizan, K., Lurie, N., Keane, D., & Bindman, A. B. (1996) · New England Journal of Medicine

Diversity and Career in MedicineGlobal Health Workforce Issues

Cited by 915

Changes in Plasma Lipids and Lipoproteins in Overweight Men during Weight Loss through Dieting as Compared with Exercise

Wood, P. D., Stefanick, M. L., Dreon, D. M., Frey-Hewitt, B., Garay, S. C., Williams, P. T., Superko, H. R., Fortmann, S. P., Albers, J. J., Vranizan, K. M., et al. (1988) · New England Journal of Medicine

Diabetes, Cardiovascular Risks, and LipoproteinsLipoproteins and Cardiovascular Health

Cited by 675

Time- and exercise-dependent gene regulation in human skeletal muscle

Zambon, A. C., McDearmon, E. L., Salomonis, N., Vranizan, K. M., Johansen, K. L., Adey, D., Takahashi, J. S., Schambelan, M., & Conklin, B. R. (2003) · Genome Biology

Circadian rhythm and melatoninMuscle Physiology and Disorders

Cited by 254

The effects of weight loss by exercise or by dieting on plasma high-density lipoprotein (HDL) levels in men with low, intermediate, and normal-to-high HDL at baseline

Williams, P. T., Stefanick, M. L., Vranizan, K. M., & Wood, P. D. (1994) · Metabolism

Lipoproteins and Cardiovascular HealthDiabetes, Cardiovascular Risks, and Lipoproteins

Cited by 106